Cost of H7N9 outbreak tops $6.5B; Sanofi's Indian vaccine biz preps for WHO visit;

@FiercePharma: What we talk about when we talk about pharma. Commentary | Join our LinkedIn group | Follow @FiercePharma

> The United Nations reports the H7N9 bird flu outbreak has cost $6.5 billion so far. Item

> Sanofi-owned Shantha Biotech is readying its 5-in-1 vaccines for re-inspection by the WHO. News

> Low vaccination rates in Ukraine could allow polio to re-enter Europe. Feature

> A TEDGlobal presentation has talked up the potential of a needle-free vaccine patch. Article

> Immunomic Therapeutics has raised $3 million to develop a Japanese red cedar allergy vaccine. Piece

> A study has found no evidence the MMR vaccine worsens juvenile arthritis. Study

> Brazil is to produce a H1N1 vaccine. Item

> Iran has reportedly succeeded in producing a vaccine for foot and mouth disease. News

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.